Page last updated: 2024-08-17

dextroamphetamine and deferoxamine

dextroamphetamine has been researched along with deferoxamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Boeck, CR; Dal-Pizzol, F; Kapczinski, F; Oliveira, VB; Petronilho, FC; Quevedo, J; Réus, GZ; Steckert, AV; Valvassori, SS1
Andersen, KJ; Febbraro, F; Romero-Ramos, M; Sanchez-Guajardo, V; Tentillier, N1

Reviews

1 review(s) available for dextroamphetamine and deferoxamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for dextroamphetamine and deferoxamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, May-15, Volume: 32, Issue:4

    Topics: Acetylcysteine; Animals; Bipolar Disorder; Central Nervous System Stimulants; Deferoxamine; Dextroamphetamine; Free Radical Scavengers; Hyperkinesis; Male; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar

2008
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Experimental neurology, 2013, Volume: 247

    Topics: Administration, Intranasal; alpha-Synuclein; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Line, Transformed; Corpus Striatum; Deferoxamine; Dextroamphetamine; Disease Models, Animal; Female; Forelimb; Gene Expression Regulation; Genetic Vectors; Humans; Motor Activity; Nerve Tissue Proteins; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Siderophores; Time Factors; Transfection; Tyrosine 3-Monooxygenase

2013